(Q42740230)
Statements
1 reference
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors. (English)
1 reference
J Baselga
1 reference
J-C Soria
1 reference
J Cortes
1 reference
C Massard
1 reference
J-P Armand
1 reference
D De Andreis
1 reference
S Ropert
1 reference
E Lopez
1 reference
A Catteau
1 reference
J James
1 reference
J-F Marier
1 reference
M Beliveau
1 reference
R E Martell
1 reference
16 May 2011
1 reference
1 reference
23
1 reference
2
1 reference
463-471
1 reference
Identifiers
1 reference
1 reference